Company News, Regulations

More Warning Letters from FDA

Claims get three new firms in hot water with the agency.

Author Image

By: Christine Esposito

Editor-in-Chief

FDA has issued three more warning letters to company making claims that the agency contends go to far.   A letter sent to Federico Sanchez, owner of Miami, FL-based Menscience Androceuticals, came following a review of its website http://www.menscience.com/ in May 2016 where the firm is taking orders for an Anti-Aging Formula. The claims on your website establish that the product is a drug under sections 201(g)(1)(B) and/or 201(g)(1)(C) of the Federal Food, Drug, and Cosmetic Act (the Act) [21...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters